• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Interferon alfa-2a Approval Information - Licensing Action

Proper name: Interferon alfa-2a
Tradename: Roferon-A
Manufacturer: Hoffman-La Roche Inc, Nutley, New Jersey, License #0136
Indication for Use: Revised package insert to provide for an induction regimen of 6 MIU three times a week for 12 weeks followed by the standard regimen given for an additional 12-36 weeks
Approval Date: 11/17/99
Type of submission: Biologics license supplement

 


Approval Letter PDF

Reviews (PDF)
      Biostatistical
      Clinical
      Epidemiology